Table 2.
List of deketene curcumin and its derivatives utilized for docking study with aromatase and Erα+
Ligand no | Compound | 2D Structure and 3D Structure | Active against | Reference |
---|---|---|---|---|
DKC-1 | 1,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadiene-3-one |
![]() |
B78H1 melanoma Cells, human colorectal carcinoma cells |
[31, 41] |
DKC-2 | 1,5-bis(4-hydroxy-3-methoxyphenyl)pent-1,4-dien-3-ylidenmalononitrile |
![]() |
human tumor cell lines as lung carcinoma NCI-460, melanoma UACC-62, breast MCF-7, colon HT-29, renal 786-O, ovarian OVCAR-03 and ovarian expressing | [33] |
DKC-3 | 1,5-bis(4-hydroxy-3-methoxyphenyl)pent-1,4-dien-3-ylidenmalononitrile |
![]() |
human tumor cell lines as lung carcinoma NCI-460, melanoma UACC-62, breast MCF-7, colon HT-29, renal 786-O, ovarian OVCAR-03 and ovarian expressing | [32] |
DKC-4 | (1E,4E)-1,5-bis(4-((tetrahydro-2H-pyran-2-yl)oxy)phenyl)penta-1,4-dien-3-one |
![]() |
Active against HL-60 cell line | [32] |
DKC-5 | (1E,4E)-1,5-bis(4-hydroxy-3,5-dimethoxyphenyl)penta-1,4-dien-3-one |
![]() |
human colorectal cancer cell lines, Antioxident | [31, 42] |
DKC-6 | ((1E,4E)-3-oxopenta-1,4-diene-1,5-diyl)bis(2-methoxy-4,1-phenylene) bis(sulfamate) |
![]() |
growth inhibitory activities on both prostate and breast cancer lines | [43] |
DKC-7 | ((1E,4E)-3-oxopenta-1,4-diene-1,5-diyl)bis(2,6-dimethoxy-4,1-phenylene) bis(sulfamate) |
![]() |
growth inhibitory activities on both prostate and breast cancer lines | [43] |
DKC-8 | (1E,4E)-1,5-bis(3,5-bis(methoxymethoxy)phenyl)penta-1,4-dien-3-one |
![]() |
Cell growth inhibition against HCT116 | [44] |
DKC-9 | (1E,4E)-1,5-bis(4-hydroxy-3-methoxyphenyl)penta-1,4-dien-3-one |
![]() |
inhibit the HIV-1 IN in enzyme assays, Antioxidant | [42, 45] |
DKC-10 | N-(10-((1-((2,6-dimethoxy-4-((1E,4E)-3-oxo-5-(3,4,5-trimethoxyphenyl)penta-1,4-dien-1-yl)phenoxy)methyl)-1H-1,2,3-triazol-4-yl)methoxy)decyl)-4-((3aS,5S,6aR)-2-oxohexahydro-1H-thieno[2,3-d]imidazol-5-yl)butanamide |
![]() |
Cell growth inhibition against HCT116 | [44] |
DKC-11 | (1E,4E)-1,5-bis(3,5-bis(2-methoxyethoxy)phenyl)penta-1,4-dien-3-one |
![]() |
Cell growth inhibition against HCT116 | [44] |
DKC-12 | (1E,4E)-1,5-bis(3,5-bis(2-hydroxyethoxy)phenyl)penta-1,4-dien-3-one |
![]() |
Cell growth inhibition against HCT116 | [44] |
DKC-13 | (1E,4E)-1,5-bis(3,5-bis((2-methoxyethoxy)methoxy)phenyl)penta-1,4-dien-3-one |
![]() |
Cell growth inhibition against HCT116 | [44] |
DKC-14 | (1E,4E)-1-(Benzo[d][1,3]dioxol-5-yl)-5-(3,5-bis(methoxymethoxy)phenyl)penta-1,4-dien-3-one |
![]() |
Cell growth inhibition against HCT116 | [44] |
DKC-15 | (E)-ethyl 2-cyano-5-(4-hydroxy-3-methoxyphenyl)-3-((E)-4-hydroxy-3-methoxystyryl)penta-2,4-dienoate |
![]() |
Lung tumor, Melanoma, Normal mamma tumor, (Mamma tumor which expresses the phenotype resistance against multiple drugs), Colon tumor, Renal tumor, Ovary tumor, Prostate tumor, Leukemia | [46] |
DKC-16 | (1E,4E)-1,5-bis(4-hydroxy-3-methoxy-5-(3-methylbut-2-en-1-yl)phenyl)penta-1,4-dien-3-one |
![]() |
Against various tumor: Lung tumor, Melanoma, Normal mamma tumor, Colon tumor, Renal tumor, Ovary tumor, Prostate tumor, Leukemia | [46] |
DKC-17 | (E)-ethyl 2-cyano-5-(4-hydroxy-3-methoxyphenyl)-3-((E)-4-hydroxy-3-methoxystyryl)penta-2,4-dienoate |
![]() |
Against various tumor: Lung tumor, Melanoma, Normal mamma tumor, Colon tumor, Renal tumor, Ovary tumor, Prostate tumor, Leukemia | [46] |
DKC-18 | (1E,4E)-1,5-bis(3,4-dihydroxyphenyl)penta-1,4-dien-3-one |
![]() |
Against various tumor: Lung tumor, Melanoma, Normal mamma tumor, Colon tumor, Renal tumor, Ovary tumor, Prostate tumor, Leukemia | [46] |
DKC-19 | (1E,4E)-1,5-bis(3-bromo-5-methoxy-4-((3-methylbut-2-en-1-yl)oxy)phenyl)penta-1,4-dien-3-one |
![]() |
Against various tumor: Lung tumor, Melanoma, Normal mamma tumor, Colon tumor, Renal tumor, Ovary tumor, Prostate tumor, Leukemia | [46] |
DKC-20 | (1E,4E)-1-(4,5-dihydroxy-2,3-bis(3-methylbut-2-en-1-yl)phenyl)-5-(4,5-dihydroxy-3-(3-methylbut-2-en-1-yl)-2-(4-methylpent-3-en-1-yl)phenyl)penta-1,4-dien-3-one |
![]() |
Against various tumor: Lung tumor, Melanoma, Normal mamma tumor, Colon tumor, Renal tumor, Ovary tumor, Prostate tumor, Leukemia | [46] |
DKC-21 | 1,5-Bis-(4-hydroxy-3-methoxy-5-morpholin-4-ylmethylphenyl)-penta-1,4-dien-3-one |
![]() |
against HL-60 neoplasms and HSC-2, HSC-3 and HSC-4 carcinoma cells | [47] |
DKC-22 | 1,5-Bis-(4-hydroxy-3-methoxy-5-pyrrolidin-1-ylmethylphenyl)-penta-1,4-dien-3-one |
![]() |
against HL-60 neoplasms and HSC-2, HSC-3 and HSC-4 carcinoma cells | [47] |
DKC-23 | 1,5-Bis-[4-hydroxy-3-methoxy-5-(4-methyl-piperazin-1-ylmethyl)-phenyl]-penta-1,4-dien-3-one |
![]() |
against HL-60 neoplasms and HSC-2, HSC-3 and HSC-4 carcinoma cells | [47] |
DKC-24 | 1,5-Bis-(3-diethylaminomethyl-4-hydroxy-5-methoxyphenyl)-penta-1,4-dien-3-one |
![]() |
against HL-60 neoplasms and HSC-2, HSC-3 and HSC-4 carcinoma cells | [47] |
DKC-25 | 1,5-Bis-(4-hydroxy-3-methoxy-5-piperidin-1-ylmethylphenyl)-penta-1,4-dien-3-one |
![]() |
against HL-60 neoplasms and HSC-2, HSC-3 and HSC-4 carcinoma cells | [47] |